Pharma Pulse 4/25/24: Advocate for Greater Pharmacy Technician Roles, Global COVID-19 Vaccines Strategic Research Report 2024 & more

Incyte Corporation Inks Deal to Acquire Escient Pharmaceuticals for $750 Million

Deal gives Incyte access to Escient’s pipeline of oral MRGPR antagonists, including EP262 and EP547.

Advocate for Greater Pharmacy Technician Roles

Multiple state and federal laws since the COVID-19 pandemic highlight the growing role of technicians.

Meta’s A.I. Assistant Is Fun to Use, but It Can’t Be Trusted

Despite Mark Zuckerberg’s hope for the chatbot to be the smartest, it struggles with facts, numbers and web search.

Global COVID-19 Vaccines Strategic Research Report 2024

The COVID-19 Vaccines market in the U.S. is estimated at 285 Million Doses in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of 1 Billion Doses by the year 2025. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach 1.8 Billion Doses by the year 2025.

@moderna_tx on Twitter/X:

We’re excited to announce our ongoing collaboration with @OpenAI to co-innovate with a shared vision of AI’s immense potential in the future of business and healthcare. #AI and collaborations like this will be a key component to our ability to scale and maximize our impact on patients. Watch the video below and read our blog to learn more about our work with #OpenAI: https://modernatx.com/media-center/all-media/blogs/collaboration-with-openai

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs